chinese

Charter for Lung Health

25 May 2017

Feeling the devastating impact of the global burden of suffering and deaths from lung disease,

Inspired by the impact of scientific and medical advances that are effective for preventing and treating lung disease,

 

Recognising the need for health and clean air with resultant benefits for the quality of life and well-being of individuals, and 

 

Steadfastly committed to a global alliance of people living with lung disease, their family and friends, health-care workers, scientists, advocates, funders, industry, government, and the public working together to prevent and treat lung disease,

 

We, the signatories, commit to strengthening strategies to prevent, treat, and cure respiratory disease to attain optimal health, and we hold ourselves accountable to the following principles:


Article I

 

Lung health is a universal human need that is often impaired by unhealthy air. Recognizing the human right to breathe safe air and that lung health is pivotal to the well-being of individuals throughout the world,

The signatories to this Charter advocate for clean air and healthy lungs as a key component of human health and well-being, and for its global recognition.

The signatories further reaffirm Article 25 of the Universal Declaration of Human Rights that states that every individual “has the right to a standard of living adequate for the health and well-being of himself and of his family, including food, clothing, housing, and medical care” and the United Nations Sustainable Development Goals to reduce death and illness due to pollution.


Article II

 

Under-recognition of lung disease is a significant challenge to achieving health around the world.

Lack of knowledge and awareness results in:

  • Preventable deaths and hospitalisation

  • Undue physical and emotional suffering to patients and their families,

  • Reduced capacity for individuals to work and contribute to their families, communities, and countries,

  • Escalating health care costs and suffering when diagnosis is delayed and treatment options limited, and

  • Increasing financial burden to national health care budgets and expenditures.

The signatories to this Charter will actively work with people, health care stakeholders, and governments to raise awareness and understanding of lung health and available, effective, preventable, and treatment strategies.


Article III

 

Addressing preventable causes of lung disease is pivotal for the development and maintenance of healthy lungs. Poor lung health is a barrier to the economic and social development of nations. Better lung health will help nations reach the health goals determined by the United Nations and World Health Organization.

Preventable causes include environmental and behavioural exposures that impair an individual’s ability to develop and maintain healthy lungs. These include:

  • Air pollution (both indoor and outdoor) and other environmental factors, 

  • Tobacco smoking,

  • Workplace exposures to pathogenic dust and fibres,

  • Over-crowding, malnutrition, lack of breastfeeding, poverty, and other factors that increase disease susceptibility and allow transmission of respiratory infections including inadequate access to vaccinations,

  • HIV disease, and 

  • Pneumonia in early childhood

The signatories to this Charter will undertake work to better understand, and eliminate preventable lung disease, including effective interventions such as strengthened childhood immunisation globally,
promoting clean air, and supporting the implementation of the 
WHO Framework Convention on Tobacco Control (WHO FCTC).

The signatories highlight the importance of optimising child lung health as a precursor to lung health for life.


Article IV


Every individual with lung disease should have access to effective management strategies. Barriers to care, especially in low and middle income countries, relate to:

  • Inadequate global recognition of the burden and impact of acute and chronic lung disease,
  • Cost of health care and insufficient national health expenditure and health policies,
  • Lack of strong health systems and capacity or availability of appropriate health care providers, and

  • Inequity in access to quality care due to poverty, stigma, distance, or cultural perception.

Optimal lung health care requires:

  • Affordable access to effective preventive strategies,
  • Timely access to appropriate treatments regardless of where a person lives,
  • Adequate and organised health care systems, and

  • Reduction of knowledge gaps by developing appropriate and affordable education and training for health care providers such as:
    • Enabling evidence-based practice relevant to expectations of patients and their communities,
    • Systematic training, educational programs and opportunities, and
    • Implementing guidelines based on the best available evidence for the prevention, diagnosis, treatment of respiratory disease

 

The signatories to this Charter will actively develop and support activities that optimise the access of all people to effective lung health interventions.


Article V


Human health continues to improve with interventions that are the result of high quality research in public health, epidemiology, basic science, and clinical research. Each is critical for a coordinated approach to healthy lungs.

Research into lung health is uneven around the world. As a consequence, advanced research may have limited applicability in a low or middle income countries constrained by funding and resources and not well targeted to the varying needs of different communities. Further specific groups such as children, women, or ethnic minorities have often been overlooked in research.

Successful and beneficial research output is challenged by funding gaps, immature research infrastructure, workforce capacity, and poorly coordinated, unprioritised topics, as well as lack of awareness and participation. 

 

The signatories to this Charter agree to support research into lung health that is ethical, inclusive, and high quality to achieve and maintain global lung health.


Article VI

 

No nation is spared from lung disease, and no person, organisation, or country will conquer lung disease on its own. 

A coordinated global approach, that promotes collaboration and networks, is needed to achieve global lung health through prevention, treatment, advocacy, and research strategies. We are all connected by the air we share.

The signatories to this Charter agree to:

Declare September 25 to be World Lung Day to ensure that the critical importance of lung health is recognised worldwide

Participate in a global alliance to support and report progress in lung health against the Articles in the Charter, and

Activate community and organisational support for the Charter by rallying 100,000 people around the world to sign the Charter for Lung Health, thereby demonstrating their willingness to support the right of every person to achieve and maintain lung health.

 

 


 

 

Signed the 25th day of May, 2017

Gerard Silvestri, MD

President, American College of Chest Physicians (CHEST)

 

Kwun Fong, MD

President, Asian Pacific Society of Respirology (APSR)

 

Andres Palomar, MD

President, Asociación Latinoamericana de Tórax (ALAT)

 

Marc Moss, MD

President, American Thoracic Society (ATS)

 

Guy Joos, MD

President, European Respiratory Society (ERS)

 

Søren Erik Pedersen, MD

Chair, Board of Directors, Global Initiative for Asthma (GINA)

 

Alvar Agusti, Chair, MD

Chair, Board of Directors, Global Initiative for Obstructive Lung Disease (GOLD)

 

Jeremiah Chakaya, MD

President, International Union Against Tuberculosis and Lung Disease (The Union)

 

Heather Zar, MD

President, Pan-African Thoracic Society (PATS)

Greetings!  Today at ATS, representatives from NIH, the COPD Foundation, and the Alpha-1 Foundation officially presented the COPD National Action Plan. This is, of course, a big deal in the respiratory community, but it can also be an important thing for us at WMed.  Secondary to my participation at the COPD Town Hall last year, and my ongoing work during the commentary period, the medical school has been included in the list of organizations “that have an interest in COPD and the COPD National Action Plan.”  We are alongside organizations like AHRQ, ACCP, Ascension Health, the Cleveland Clinic, Johns Hopkins, and U-M/Michigan Medicine.  Additionally, the Frequently Asked Questions section of the companion website states, “a list of organizations already expressing interest and enthusiasm in activities aligned with the goals of the COPD National Action Plan can be found in the plan. If you are served by these organizations in any way, you should feel free to reach out to them directly.”  Again, that’s us. (I attached a copy of the report; we’re alphabetically last, on page 46.)

 

At the end of the presentation, there was a Q&A and additional remarks by Dr. Byron Thomashow of New York-Presbyterian, chair of the COPD Foundation and one of the main architects of the NAP.  Notably, two of his comments were, “This disease LIVES in primary care” and, “We can make their lives better TODAY [through the engagement of primary care clinicians].” We can use this as some of that outreach you were talking about, because this is exactly what we’re doing here on Oakland Drive.

 

We could easily put together a release putting all this stuff forward and present ourselves as being on the cutting edge of practice, etc. etc.  I wanted to run this by you, and see what you thought about one of us talking to Laura Eller and getting something out to the community.